13 November 2019

Toxicology in Vitro

Toxicology in Vitro publishes original research papers and reviews on the application and use of in vitro systems for assessing or predicting the toxic effects of chemicals and elucidating their mechanisms of action. These in vitro techniques include utilizing cell or tissue cultures, isolated cells, tissue slices, subcellular fractions, transgenic cell cultures, and cells from transgenic organisms, as well as in silico modelling. The Journal focuses on investigations that involve the development and validation of new in vitro methods, e.g. for prediction of toxic effects based on traditional and in silico modelling; on the use of methods in high-throughput toxicology and pharmacology; elucidation of mechanisms of toxic action; the application of genomics, transcriptomics and proteomics in toxicology, as well as on comparative studies that characterize the relationship between in vitro and in vivo findings.
The Journal strongly encourages the submission of manuscripts that focus on the development of in vitro methods, their practical applications and regulatory use (e.g. in the areas of food components cosmetics, pharmaceuticals, pesticides, and industrial chemicals).

The Latest News from TIV (RSS feed):

                               

                               

                               

                               

                               

Related content

ATLA Launching 4 special issues on NAMs!

The four special virtual issues are focusing on: Biobanking, In silico tools, Serum-free approaches and Educational resources. Prompt publishing and no submission or publication fees payable.

APRIL ESTIV-ASCCT Webinar: Legal and Policy Considerations for in the Use of New Approach Methodologies (NAMs) in Chemical Risk Assessment

APRIL ESTIV-ASCCT Webinar: Legal and Policy Considerations for in the Use of New Approach Methodologies (NAMs) in Chemical Risk Assessment – with Gary Marchant, PhD, JD, Sandra Day O’Connor College of Law, Arizona State U. and Kirk T. Hartley, JD, ToxicoGenomica and LSP Group LLC

Webinar + Guidance on gaining acceptance in next generation PBK modelling approaches for regulatory approaches – May 10, 2021

  • News

If you are from the community of PBK model developers, or the proponent of a model in a regulatory submission, or a regulator who needs to assess the applicability of the models in chemical evaluations, this webinar is for you!

Corporate Members

mattek in Vitro Life Science Laboratories

Affiliated Societies

Invitrom Celltox IVTS

Memorandum of Understanding